Related Experiment Videos
[Psychopharmaceuticals and breast feeding]
1Klinische Abteilung für Sozialpsychiatrie u. Evaluationsforschung, Universitätsklinik für Psychiatrie AKH Wien. stefan.fruehwald@univie.ac.at
Psychiatrische Praxis
|March 30, 2000
Summary
Breastfeeding may be safe for infants of mothers on psychotropic medication. Careful risk-benefit analysis and monitoring are crucial, with benefits potentially outweighing risks.
Area of Science:
- Perinatology
- Psychopharmacology
- Infant Nutrition
Background:
- Postnatal mental health disorders are common and may require psychotropic medication.
- The decision to breastfeed while on medication presents a complex risk-benefit scenario for mother and infant.
Observation:
- This review synthesizes current data on the benefits and risks of breastfeeding for infants whose mothers are undergoing psychotropic pharmacotherapy.
- A thorough risk-benefit assessment is necessary if a mother chooses to breastfeed.
Findings:
- Emerging evidence suggests that the advantages of breastfeeding can outweigh the risks associated with maternal pharmacotherapy.
- This holds true when minimal effective drug dosages are used, particularly for medications with low transfer into breast milk.
Implications:
- Close monitoring of the nursing infant for adverse effects is essential, especially during the initial three months postpartum.
- Serum drug level monitoring in the infant may be advisable in certain situations.
- Informed decisions regarding breastfeeding and psychotropic medication can be made through careful consideration of individual circumstances.